{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Cohort+B%29&page=17", "query": { "intervention": "Placebo (Cohort B)", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 425, "total_pages": 43, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Cohort+B%29&page=18&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Cohort+B%29&page=16&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T08:29:36.116Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05138653", "title": "A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "CVL-354", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerevel Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 73, "start_date": "2021-10-18", "completion_date": "2023-01-23", "has_results": true, "last_update_posted_date": "2024-11-26", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05138653" }, { "nct_id": "NCT04449029", "title": "A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis B" ], "interventions": [ { "name": "GSK3228836", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Nucleos(t)ide therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 457, "start_date": "2020-07-27", "completion_date": "2022-03-18", "has_results": true, "last_update_posted_date": "2023-05-16", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 8, "location_summary": "Los Angeles, California • Miami, Florida • Decatur, Georgia + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04449029" }, { "nct_id": "NCT03890302", "title": "Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704A", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "FB704A", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fountain Biopharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 31, "start_date": "2019-03-14", "completion_date": "2020-05-27", "has_results": false, "last_update_posted_date": "2020-07-21", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03890302" }, { "nct_id": "NCT05385783", "title": "A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "CYB003", "type": "DRUG" }, { "name": "Psychotherapy", "type": "BEHAVIORAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Psychological Support", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Cybin IRL Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 57, "start_date": "2022-08-02", "completion_date": "2024-01-18", "has_results": false, "last_update_posted_date": "2024-03-25", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 3, "location_summary": "Atlanta, Georgia • Decatur, Georgia • Eatontown, New Jersey", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Eatontown", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05385783" }, { "nct_id": "NCT06602479", "title": "A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "MEDI0618", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 488, "start_date": "2024-10-07", "completion_date": "2027-05-07", "has_results": false, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • La Jolla, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Homestead", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06602479" }, { "nct_id": "NCT01453296", "title": "Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GW642444", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "5 Years to 11 Years" }, "enrollment_count": 28, "start_date": "2010-08", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2017-01-13", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 5, "location_summary": "Cypress, California • Huntington Beach, California • Denver, Colorado + 2 more", "locations": [ { "city": "Cypress", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Normal", "state": "Illinois" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT01453296" }, { "nct_id": "NCT01428297", "title": "A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Atopic Dermatitis", "Netherton Syndrome" ], "interventions": [ { "name": "BPR277 ointment (controlled application)", "type": "DRUG" }, { "name": "Placebo (Vehicle)", "type": "DRUG" }, { "name": "BPR277 ointment", "type": "DRUG" }, { "name": "BPR277", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2011-05", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2020-12-08", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 3, "location_summary": "New Haven, Connecticut • St Louis, Missouri • Fargo, North Dakota", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01428297" }, { "nct_id": "NCT06489548", "title": "Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dementia", "Alzheimers Disease", "Mild Cognitive Impairment Due to Alzheimer's Disease" ], "interventions": [ { "name": "Foralumab TZLS-401 50 µg", "type": "DRUG" }, { "name": "Foralumab TZLS-401 100 µg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "60 Years to 85 Years" }, "enrollment_count": 16, "start_date": "2025-09-16", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06489548" }, { "nct_id": "NCT05318040", "title": "Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "CMS121", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Virogenics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "19 Years to 85 Years" }, "enrollment_count": 99, "start_date": "2022-05-01", "completion_date": "2022-12-17", "has_results": false, "last_update_posted_date": "2023-02-16", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT05318040" }, { "nct_id": "NCT06834789", "title": "A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glabellar Lines" ], "interventions": [ { "name": "AGN-151586", "type": "DRUG" }, { "name": "OnabotulinumtoxinA", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 132, "start_date": "2025-02-18", "completion_date": "2025-11-03", "has_results": false, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-10-14T08:29:36.116Z", "location_count": 8, "location_summary": "Scottsdale, Arizona • Newport Beach, California • Redondo Beach, California + 5 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Redondo Beach", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Chestnut Hill", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06834789" } ] }